International medullary thyroid carcinoma grading system: an Indian tertiary care centre experience
- PMID: 38010402
- DOI: 10.1007/s00405-023-08341-x
International medullary thyroid carcinoma grading system: an Indian tertiary care centre experience
Abstract
Introduction: Medullary carcinoma (MTC) is a rare neuroendocrine thyroid neoplasm. The international medullary thyroid carcinoma grading scheme (IMTCGS), which has prognostic significance, has been introduced recently. The present study graded MTC cases using the IMTCGS and evaluated it in our study cohort.
Methods: All MTC thyroidectomy cases over 6 years were evaluated. Low-grade (LG) and high-grade (HG) were compared. Survival analysis included overall survival (OS), loco-regional free survival and distant metastasis free survival (DMFS).
Results: Of 32 cases, 31.25% were HG and 68.75% LG. The mean age was 44.0 years and M:F ratio 1:1.146. HG patients were older and had tumour cells with high-grade nuclear features and prominent nucleoli and showed distant metastasis. Necrosis was found more in patients with high grade nuclear features. There was discordance between the high Ki67 (60%) and increased mitotic activity (20%). Univariate survival analysis revealed poor DMFRS and OS in the cohorts with high grade, Ki67 > 5% and coagulative necrosis. The multivariate cox regression analysis showed IMTCGS significantly associated with overall survival (HR 28.30, p = 0.009) and DMFS (HR 15.70, p = 0.02).
Discussion and conclusion: This is the first Indian study evaluating IMTCGS, a very simple and convenient grading system that can be readily used in any tertiary health care centre. IHC for Ki 67 should mandatorily be done irrespective of the low mitotic activity on the HPE and necrosis should be diligently searched in cases with high-grade nuclear morphology. HG MTC cohorts were associated with poor OS as well as DMFRS.
Keywords: Grading; High grade; IMTCGS; Ki67 index; Medullary carcinoma thyroid; Mitosis; Necrosis.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Independent Validation of the International Grading System for Medullary Thyroid Carcinoma: A Single Institution Experience.Mod Pathol. 2023 Sep;36(9):100235. doi: 10.1016/j.modpat.2023.100235. Epub 2023 Jun 1. Mod Pathol. 2023. PMID: 37270155 Free PMC article.
-
Grading medullary thyroid carcinoma on fine-needle aspiration cytology specimens with the International Medullary Thyroid Carcinoma Grading System: A cytologic-histologic correlation.Cancer Cytopathol. 2024 Apr;132(4):224-232. doi: 10.1002/cncy.22778. Epub 2023 Dec 8. Cancer Cytopathol. 2024. PMID: 38062948
-
Tumor Grade Predicts for Calcitonin Doubling Times and Disease-Specific Outcomes After Resection of Medullary Thyroid Carcinoma.Thyroid. 2022 Oct;32(10):1193-1200. doi: 10.1089/thy.2022.0217. Epub 2022 Sep 20. Thyroid. 2022. PMID: 35950622 Free PMC article.
-
Update on C-Cell Neuroendocrine Neoplasm: Prognostic and Predictive Histopathologic and Molecular Features of Medullary Thyroid Carcinoma.Endocr Pathol. 2023 Mar;34(1):1-22. doi: 10.1007/s12022-023-09753-5. Epub 2023 Mar 8. Endocr Pathol. 2023. PMID: 36890425 Review.
-
Surgical management of medullary thyroid carcinoma.Updates Surg. 2017 Jun;69(2):151-160. doi: 10.1007/s13304-017-0443-y. Epub 2017 Apr 13. Updates Surg. 2017. PMID: 28409442 Review.
Cited by
-
Validation of the International Medullary Thyroid Cancer Grading System and Identification of EZH2 as a Prognostic and Potential Therapeutic Marker in Medullary Thyroid Cancer.Cancers (Basel). 2025 Feb 21;17(5):737. doi: 10.3390/cancers17050737. Cancers (Basel). 2025. PMID: 40075585 Free PMC article.
References
-
- Lloyd RV, Osamura RY, Klöppel G, Rosai J (2017) WHO classification of tumours of endocrine organs, 4th edn. Lyon
-
- Horn RC (1951) Carcinoma of the thyroid: description of a distinctive morphological variant and report of seven cases. Cancer 4:697–707 - DOI
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical